Albendazole Treatment of Echinococcosis in Humans: Effects on Microsomal Metabolism and Drug Tolerance
Studysummary In this study, albendazole treatment in patients with hydatid disease was associated with decreased microsomal enzyme function and induced its own metabolism, but also showed potential hepatotoxicity and severe side effects, necessitating careful monitoring. Our plain-language summary of this paper — not a Tressless recommendation.
The study on albendazole treatment for echinococcosis in 20 patients found that the drug inhibited microsomal enzyme function and induced its own metabolism, leading to decreased plasma levels of albendazole sulfoxide in some patients. Significant side effects included hepatotoxicity, neutropenia, and alopecia, with 50% of patients experiencing hair loss and one case of total alopecia. The findings underscored the importance of close therapeutic monitoring due to the substantial incidence of adverse effects.
